栄研化学の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/11/14 | 1,558 | 1,573 | 1,533 | 1,555 | +45 | +3% | 190,500 |
2023/11/13 | 1,525 | 1,542 | 1,510 | 1,510 | -25 | -1.6% | 87,600 |
2023/11/10 | 1,536 | 1,545 | 1,522 | 1,535 | -16 | -1% | 186,100 |
2023/11/09 | 1,540 | 1,558 | 1,540 | 1,551 | +13 | +0.8% | 187,000 |
2023/11/08 | 1,528 | 1,539 | 1,516 | 1,538 | +9 | +0.6% | 368,500 |
2023/11/07 | 1,506 | 1,530 | 1,506 | 1,529 | +28 | +1.9% | 288,100 |
2023/11/06 | 1,521 | 1,525 | 1,497 | 1,501 | -11 | -0.7% | 265,200 |
2023/11/02 | 1,500 | 1,517 | 1,484 | 1,512 | +9 | +0.6% | 236,900 |
2023/11/01 | 1,505 | 1,516 | 1,492 | 1,503 | +18 | +1.2% | 336,700 |
2023/10/31 | 1,436 | 1,491 | 1,423 | 1,485 | +40 | +2.8% | 419,400 |
2023/10/30 | 1,427 | 1,452 | 1,415 | 1,445 | -5 | -0.3% | 1,318,700 |
2023/10/27 | 1,479 | 1,509 | 1,426 | 1,450 | +31 | +2.2% | 624,600 |
2023/10/26 | 1,442 | 1,444 | 1,413 | 1,419 | -22 | -1.5% | 300,400 |
2023/10/25 | 1,464 | 1,468 | 1,437 | 1,441 | -12 | -0.8% | 308,800 |
2023/10/24 | 1,430 | 1,457 | 1,416 | 1,453 | +9 | +0.6% | 311,600 |
2023/10/23 | 1,464 | 1,469 | 1,443 | 1,444 | -19 | -1.3% | 222,000 |
2023/10/20 | 1,440 | 1,465 | 1,437 | 1,463 | +28 | +2% | 209,900 |
2023/10/19 | 1,415 | 1,442 | 1,415 | 1,435 | +14 | +1% | 122,900 |
2023/10/18 | 1,439 | 1,444 | 1,418 | 1,421 | -3 | -0.2% | 104,100 |
2023/10/17 | 1,439 | 1,451 | 1,416 | 1,424 | -11 | -0.8% | 142,500 |
2023/10/16 | 1,432 | 1,446 | 1,428 | 1,435 | +3 | +0.2% | 164,600 |
2023/10/13 | 1,444 | 1,444 | 1,428 | 1,432 | -5 | -0.3% | 191,900 |
2023/10/12 | 1,425 | 1,438 | 1,418 | 1,437 | +2 | +0.1% | 174,900 |
2023/10/11 | 1,406 | 1,436 | 1,405 | 1,435 | +17 | +1.2% | 201,200 |
2023/10/10 | 1,402 | 1,420 | 1,399 | 1,418 | +24 | +1.7% | 234,100 |
2023/10/06 | 1,376 | 1,396 | 1,376 | 1,394 | +18 | +1.3% | 186,000 |
2023/10/05 | 1,349 | 1,379 | 1,348 | 1,376 | +36 | +2.7% | 230,400 |
2023/10/04 | 1,336 | 1,356 | 1,334 | 1,340 | +1 | +0.1% | 214,300 |
2023/10/03 | 1,360 | 1,367 | 1,337 | 1,339 | -26 | -1.9% | 245,300 |
2023/10/02 | 1,378 | 1,389 | 1,362 | 1,365 | -1 | -0.1% | 195,500 |
2023/09/29 | 1,369 | 1,374 | 1,358 | 1,366 | -3 | -0.2% | 148,200 |
2023/09/28 | 1,373 | 1,377 | 1,362 | 1,369 | -29 | -2.1% | 150,000 |
2023/09/27 | 1,381 | 1,398 | 1,369 | 1,398 | +14 | +1% | 182,200 |
2023/09/26 | 1,391 | 1,392 | 1,381 | 1,384 | -10 | -0.7% | 128,300 |
2023/09/25 | 1,391 | 1,396 | 1,383 | 1,394 | +7 | +0.5% | 88,400 |
2023/09/22 | 1,382 | 1,392 | 1,375 | 1,387 | +2 | +0.1% | 106,500 |
2023/09/21 | 1,401 | 1,402 | 1,382 | 1,385 | -16 | -1.1% | 123,100 |
2023/09/20 | 1,427 | 1,430 | 1,400 | 1,401 | -25 | -1.8% | 156,700 |
2023/09/19 | 1,405 | 1,427 | 1,405 | 1,426 | +26 | +1.9% | 145,900 |
2023/09/15 | 1,389 | 1,405 | 1,384 | 1,400 | +24 | +1.7% | 292,900 |
2023/09/14 | 1,375 | 1,382 | 1,368 | 1,376 | -1 | -0.1% | 192,400 |
2023/09/13 | 1,380 | 1,384 | 1,372 | 1,377 | -10 | -0.7% | 183,600 |
2023/09/12 | 1,388 | 1,388 | 1,377 | 1,387 | +7 | +0.5% | 139,700 |
2023/09/11 | 1,385 | 1,389 | 1,373 | 1,380 | ±0 | ±0% | 121,600 |
2023/09/08 | 1,390 | 1,398 | 1,375 | 1,380 | -21 | -1.5% | 250,600 |
2023/09/07 | 1,406 | 1,409 | 1,397 | 1,401 | -8 | -0.6% | 139,900 |
2023/09/06 | 1,410 | 1,412 | 1,403 | 1,409 | +1 | +0.1% | 83,500 |
2023/09/05 | 1,408 | 1,413 | 1,400 | 1,408 | -6 | -0.4% | 136,500 |
2023/09/04 | 1,405 | 1,418 | 1,401 | 1,414 | +9 | +0.6% | 131,600 |
2023/09/01 | 1,400 | 1,408 | 1,395 | 1,405 | +5 | +0.4% | 173,400 |
251~
300
件表示中 / 6839件
類似銘柄と比較する
現在ご覧いただいている「栄研化」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
栄研化 | 210,100円 | +0.4% | -8.4% | 2.52% | 27.77倍 | 1.58倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
杏林製薬 | 149,100円 | +3.2% | +4.5% | 3.49% | 17.13倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
JCRファーマ | 69,600円 | -3.7% | -36.7% | 2.87% | 22.92倍 | 1.50倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
サンバイオ | 96,700円 | - | - | 0.00% | - | 48.69倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
あすかHD | 203,600円 | +0.3% | +2.7% | 2.46% | 11.55倍 | 0.90倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。21年春にあすか製薬が持株会社化 |
市場注目の銘柄
チャート関連のコラム